Shigella dysenteriae type 1 with reduced susceptibility to fluoroquinolones [6]

Lancet

Volumn 361, Issue 9359, 2003, Pages 785-

  Sarkar, K ^a   Ghosh, S ^a   Niyogi, S K ^a   Bhattacharya, S K ^a  

^a NATIONAL INSTITUTE OF CHOLERA AND ENTERIC DISEASES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; FURAZOLIDONE; GENTAMICIN; KANAMYCIN; NALIDIXIC ACID; NEOMYCIN; NORFLOXACIN; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; STREPTOMYCIN; TETRACYCLINE;

ABDOMINAL PAIN; BACTERIAL STRAIN; BRAIN DISEASE; CLINICAL FEATURE; CONVULSION; DEATH; DRUG COST; DRUG SENSITIVITY; DYSPNEA; EPIDEMIC; FATALITY; FECES ANALYSIS; FEVER; FLATULENCE; HEMATOCHEZIA; HEMATURIA; HUMAN; INDIA; LETTER; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; SHIGELLA DYSENTERIAE; SHIGELLOSIS; TEA; VOMITING;

EID: 0037334252     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(03)12644-X     Document Type: Letter

References (4)

1. Pal S.C. Epidemic bacillary dysentery in West Bengal. Lancet. 1:1984;1462.
2. Bose R., Nashipuri J.N., Sen P.K., et al. Epidemic of dysentery in West Bengal: clinicians'enigma. Lancet. 2:1984;1160.
3. Sen D., Dutta P., Deb B.C., Pal S.C. Nalidixic acid resistant Shigella dysenteriaetype 1 in eastern India. Lancet. 2:1988;911.
4. World Health Organization. Manual for the laboratory investigation of acute enteric infections. Geneva: WHO, 1987; publication number WHO/CDD/83.3 rev 1.